- Home
- VRE vs TVTX Comparison
VRE vs TVTX Comparison
Compare VRE & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRE
- TVTX
- Stock Information
- Founded
- VRE 1949
- TVTX 2008
- Country
- VRE United States
- TVTX United States
- Employees
- VRE N/A
- TVTX N/A
- Industry
- VRE Real Estate Investment Trusts
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- VRE Real Estate
- TVTX Health Care
- Exchange
- VRE Nasdaq
- TVTX Nasdaq
- Market Cap
- VRE 1.4B
- TVTX 1.5B
- IPO Year
- VRE 1994
- TVTX N/A
- Fundamental
- Price
- VRE $14.59
- TVTX $26.55
- Analyst Decision
- VRE Buy
- TVTX Strong Buy
- Analyst Count
- VRE 5
- TVTX 16
- Target Price
- VRE $19.20
- TVTX $35.20
- AVG Volume (30 Days)
- VRE 708.8K
- TVTX 2.0M
- Earning Date
- VRE 10-22-2025
- TVTX 10-30-2025
- Dividend Yield
- VRE 2.19%
- TVTX N/A
- EPS Growth
- VRE N/A
- TVTX N/A
- EPS
- VRE N/A
- TVTX N/A
- Revenue
- VRE $285,675,000.00
- TVTX $333,865,000.00
- Revenue This Year
- VRE $6.48
- TVTX $84.12
- Revenue Next Year
- VRE $1.33
- TVTX $40.82
- P/E Ratio
- VRE N/A
- TVTX N/A
- Revenue Growth
- VRE 5.04
- TVTX 87.94
- 52 Week Low
- VRE $13.69
- TVTX $12.91
- 52 Week High
- VRE $18.85
- TVTX $28.69
- Technical
- Relative Strength Index (RSI)
- VRE 39.00
- TVTX 69.57
- Support Level
- VRE $14.37
- TVTX $24.88
- Resistance Level
- VRE $15.20
- TVTX $26.53
- Average True Range (ATR)
- VRE 0.30
- TVTX 1.37
- MACD
- VRE -0.11
- TVTX -0.03
- Stochastic Oscillator
- VRE 14.45
- TVTX 82.72
About VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.